Acta Obstetricia Et Gynecologica Scandinavica · 2009 · 19 citations · 29 references
MedicineOncologySurgeryAdolescent GynecologyChemotherapyGynecologic OncologyFertility PreservationGerm Cell TumorsGynecologic Oncology SurgeryOvarian CancerOvarian NeoplasiaOvarian SurgeryAdolescent Ovarian TumorsGerm Cell Tumor ChemotherapyMalignant Ovarian NeoplasmsMalignant Ovarian TumorsMedical Records ReviewOutcome MeasuresOvarian Function AssessmentPremature Ovarian Failure
Abstract Objective. To evaluate the long-term outcome and ovarian function in premenarchal and adolescent patients with malignant ovarian germ cell tumors after fertility-preserving surgery and adjuvant chemotherapy. Design. Retrospective review of medical records. Setting. Ajou University Hospital, a tertiary care hospital in South Korea. Population. Forty-five patients with malignant ovarian germ cell tumors. Methods. A retrospective analysis of patients with malignant ovarian germ cell tumors was conducted and a statistical analysis was performed. Main outcome measures. There were 9 premenarchal and 16 adolescent patients; the median ages at diagnosis were 7 and 18 years, respectively. All patients were treated with fertility-preserving surgery. Seventeen of the patients received adjuvant chemotherapy with bleomycin, etoposide, and cisplatin (68.0%). There were no disease recurrences or deaths. Of the nine premenarchal patients, eight (88.9%) subsequently had normal menarche. Among the 16 adolescent patients, 15 (93.8%) resumed normal menstruation and 1 had premature ovarian failure. Conclusion. Premenarchal and adolescent patients with malignant ovarian germ cell tumors have excellent survival with fertility-preserving surgery and adjuvant chemotherapy. The majority of these patients can have normal menarche and menstruation.
29
Acute Ovarian Failure in the Childhood Cancer Survivor Study
Wassim Chemaitilly, Ann Mertens, Pauline Mitby et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 445 citations · Full text
Medicine, Gynecology, Oncology +10